The Art of Skipping Follow-Ups
A young IT professional comes in with mild fatigue. Routine tests are done. Everything is normal except a borderline vitamin deficiency.
He shrugs it off: “These tests are just unnecessary expenses anyway.” 
No follow-up. No discussion. Life moves on.
But in clinical practice, this mindset is more common than we think. In India, the gap in diagnostics is not always due to access or intent it is often due to understanding.
Nearly 46% of patients advised investigations do not return for follow-up, meaning results often fail to translate into action or treatment adjustments.
Many patients report difficulty understanding or acting on medical test results, especially when findings are borderline or asymptomatic.
In India, less than 1% of diagnostic laboratories are formally accredited, highlighting wide variation in quality and trust across testing facilities.
The real issue isn’t testing it’s interpretation.
A report is not just “normal” or “abnormal.” It sits on a spectrum of risk, context, and prevention.
When results are seen as either urgent crisis or useless paperwork, we miss the important middle ground where prevention actually works. 
Key takeaway:
Diagnostics are powerful only when followed by understanding, discussion, and timely action not just collection of reports.
Because medicine doesn’t end at “normal.” It begins there. 
MBH/PS